Osaka, Japan

Yohei Ikuma

USPTO Granted Patents = 12 


Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Suita, JP (2014)
  • Ibaraki, JP (2020 - 2022)
  • Osaka, JP (2013 - 2023)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovations of Yohei Ikuma

Introduction

Yohei Ikuma is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating neuropsychiatric diseases. With a total of 12 patents to his name, Ikuma's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is a medicament for treating neuropsychiatric diseases, which comprises a compound of Formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient. Another notable patent is a process for preparing substituted pyrazolo[1,5-a]pyrazines, specifically a compound of Formula (1a). These innovations highlight his commitment to advancing medical science.

Career Highlights

Ikuma has worked with reputable companies such as Sumitomo Dainippon Pharma Co., Ltd. and Sumitomo Pharma Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Ikuma has collaborated with notable colleagues, including Junya Ikeda and Hidefumi Yoshinaga. These partnerships have played a crucial role in the development of his innovative ideas and patents.

Conclusion

Yohei Ikuma's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to improving medical treatments. His work continues to influence the industry and inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…